CMT Research Foundation
Overview
A patient-led, 501(c)(3) non-profit organization focused on delivering treatments and cures for Charcot-Marie-Tooth (CMT) disease. The foundation funds and invests in scientific research and drug development, identifying and supporting promising projects with a high potential of leading to clinical trials and approved treatments.
Portfolio Companies
5
Website
cmtrf.orgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Samsara Therapeutics | Oct 2022 | Grant | Co-investor |
| ReviR Therapeutics | Jul 2024 | Series A | Co-investor |
| Augustine Therapeutics | Mar 2025 | Series A | Co-investor |
| Armatus Bio | Nov 2023 | Seed | Co-investor |
| First Atom Therapeutics | May 2025 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is CMT Research Foundation based?
CMT Research Foundation is headquartered in Atlanta, Georgia, United States.
When was CMT Research Foundation founded?
Founding year information for CMT Research Foundation is not publicly available.
How many portfolio companies does CMT Research Foundation have?
CMT Research Foundation has 5 portfolio companies in Caplight's dataset.
What are some companies in CMT Research Foundation's portfolio?
Portfolio companies visible on Caplight include Samsara Therapeutics, ReviR Therapeutics, Augustine Therapeutics, Armatus Bio, First Atom Therapeutics.
What was CMT Research Foundation's most recent investment shown here?
CMT Research Foundation's most recent investment in this portfolio sample was in First Atom Therapeutics in 2025.
What sectors does CMT Research Foundation focus on?
CMT Research Foundation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does CMT Research Foundation focus on?
CMT Research Foundation typically invests at the Early stage.
What is CMT Research Foundation's AUM?
CMT Research Foundation's assets under management are estimated between $4.3M and $4.7M.